Gary K. Lee, Chief Scientific Officer at Lyell Immunopharma, Inc. (LYEL), sold 147 shares at $23.12 ($3K) on 2026-02-10, disclosed to the SEC on 2026-02-11.
Open-market sale of $3k LYEL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LYEL | SELL | 2026-06-15 | $2K | — | Filing → |
| LYEL | SELL | 2026-02-12 | $39K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $2K | — | Filing → |